Cost-effectiveness of urinary biomarker panel in prostate cancer risk assessment

TM Govers, L Caba, MJ Resnick - The Journal of urology, 2018 - Elsevier
Purpose SelectMDx (MDxHealth®) is a panel of urinary biomarkers used in conjunction with
traditional risk factors to individualize risk prediction for clinically significant prostate cancer …
被引用次数：25 相关文章

Cost-Effectiveness of Urinary Biomarker Panel in Prostate Cancer Risk Assessment

TM Govers, L Caba, MJ Resnick - Journal of Urology, 2018 - journals.lww.com
Purpose: SelectMDx (MDxHealth®) is a panel of urinary biomarkers used in conjunction with
traditional risk factors to individualize risk prediction for clinically significant prostate cancer …

Cost-Effectiveness of Urinary Biomarker Panel in Prostate Cancer Risk Assessment

TM Govers, L Caba, MJ Resnick - The Journal of urology, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose SelectMDx (MDxHealth®) is a panel of urinary biomarkers used in conjunction with
traditional risk factors to individualize risk prediction for clinically significant prostate cancer …

Cost-Effectiveness of Urinary Biomarker Panel in Prostate Cancer Risk Assessment

TM Govers, L Caba, MJ Resnick - The Journal of Urology, 2018 - auajournals.org
Purpose: SelectMDx (MDxHealth®) is a panel of urinary biomarkers used in conjunction with
traditional risk factors to individualize risk prediction for clinically significant prostate cancer …

Cost-Effectiveness of Urinary Biomarker Panel in Prostate Cancer Risk Assessment.

TM Govers, L Caba, MJ Resnick - The Journal of Urology, 2018 - europepmc.org
Purpose SelectMDx (MDxHealth®) is a panel of urinary biomarkers used in conjunction with
traditional risk factors to individualize risk prediction for clinically significant prostate cancer …

Cost-Effectiveness of Urinary Biomarker Panel in Prostate Cancer Risk Assessment

TM Govers, L Caba, MJ Resnick - The Journal of Urology, 2018 - lifespring.nl
Purpose: SelectMDx (MDxHealth®) is a panel of urinary biomarkers used in conjunction with
traditional risk factors to individualize risk prediction for clinically significant prostate cancer …

Cost-Effectiveness of Urinary Biomarker Panel in Prostate Cancer Risk Assessment

TM Govers, L Caba, MJ Resnick - Journal of Urology, 2018 - hero.epa.gov
Purpose: SelectMDx (MDxHealth (R)) is a panel of urinary biomarkers used in conjunction
with traditional risk factors to individualize risk prediction for clinically significant prostate …